Illumina, Inc.

ILMN

$309.69

+4.26% (1 year change)

Avg closing price

Price range

Market Cap

$47.4 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

-

Total revenue in the last quarter.

Net Income

-

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$4.71

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

-

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

68.63x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

-

Earnings before interest expenses and taxes in the last quarter.

Employees

7,700

The number of full time employees.

Revenue & Earnings

Balance Sheet

Illumina, Inc.

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

News

Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market

Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market

Shares of cancer screening and diagnostics company EXACT Sciences Corporation (NASDAQ: EXAS ) were rallying to a record high Tuesday after it announced two M&A transactions and third-quarter result...

Benzinga Benzinga, 2 days ago
Illumina, Inc. (NASDAQ:ILMN) Director Jay T. Flatley Sells 4,000 Shares

Illumina, Inc. (NASDAQ:ILMN) Director Jay T. Flatley Sells 4,000 Shares

Illumina, Inc. (NASDAQ:ILMN) Director Jay T. Flatley sold 4,000 shares of Illumina stock in a transaction that occurred on Tuesday, October 20th. The stock was sold at an average price of $321.72, ...

Daily Political Daily Political, 5 days ago
Illumina (NASDAQ:ILMN) Rating Lowered to Hold at BidaskClub

Illumina (NASDAQ:ILMN) Rating Lowered to Hold at BidaskClub

Illumina (NASDAQ:ILMN) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Tuesday, BidAskClub reports. ILMN has been the topic o...

Transcript Daily Transcript Daily, 7 days ago